MMIC - ESFAM Biotech Pty Ltd: Test compounds to be supplied to a collaborator for further study.

Project: Consultancy

Project Description

ESFAM Biotech Pty Ltd (ESFAM) has developed a series of compounds that are effective inhibitors of the migration of prostate cancer cells. The compounds are not cytotoxic agents.
The company is interested in the precise and accurate preparation of fractions from 150 of its test compounds to be supplied to a collaborator for further study.
The tasks are to:
1. Take receipt of and safely store 10 – 20 mg of approximately 150 non-scheduled materials from ESFAM.
2. Weigh a single portion of 2-5 mg from each specimen into an Eppendorf tube using a six figure analytical balance. (Only one portion from each sample is required).
3. Record the weight and sample code on each vial.
4. Return the samples and fractions to ESFAM.
Short titleMMIC - ESFAM
StatusFinished
Effective start/end date1/05/1910/05/19